Patent ID: 11872029
Assignee: CLEVELAND MEDICAL DEVICES INC
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 19:
20. A positive airway pressure (PAP) sleep disorder treatment system comprising:
a non-transitory computer readable medium comprising a first software, the first software adapted to be downloaded to a cell phone and executable by a first processor on the cell phone to display to a subject for viewing on the cell phone an index of treatment efficacy of the subject using a PAP device, the index based in whole or in part on a data of severity of sleep disorder symptoms of the subject and/or a data of usage of the PAP device by the subject, the cell phone comprising at least one first radio frequency wireless transceiver, the first processor, the first software when downloaded, and a display;
the PAP device with an enclosure further comprising:
a blower having an air output,
an airflow sensor being any type of sensor internal to the enclosure of the PAP device adapted for measuring or deriving the respiratory airflow of a subject while using the PAP and outputting airflow sensor data,
a second processor adapted for receiving the airflow sensor data and for calculating:
i) the data of a severity of the sleep disorder symptoms of the subject,
ii) the data of usage of the PAP device, and/or
iii) the index based on either i) or ii) or both i) and ii),

a mask or a nasal cannula, and
at least one second radio frequency wireless transceiver, the at least one second radio frequency wireless transceiver adapted for transmitting i) and ii), and/or iii);

a second non-transitory computer readable medium comprising a second software adapted to be executable a third processor on a portable, wearable patient data acquisition device comprising a pulse oximeter and an accelerometer to collect additional physiological data from the subject for combining with the data collected by the PAP, the second software further adapted to forward the additional physiological data to combine with the data from the PAP device to determine the treatment efficacy of the subject using the PAP device; and
a remote internet site, the remote internet site adapted to receive i) and ii), or i), ii), and iii) related to the subject's treatment and the treatment's efficacy in whole or part, generated by the PAP device and transmitted via the at least one second radio frequency wireless transceiver and the additional physiological data collected with the portable, wearable patient acquisition device.